Anifrolumab in recalcitrant cutaneous dermatomyositis: A multicenter retrospective cohort study

Affiliations

¹ Section of Dermatology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: katharina.shaw@pennmedicine.upenn.edu.
² Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Dermatology Program, Division of Immunology, Boston Children's Hospital, Boston, Massachusetts.
³ Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
⁴ Division of Pediatric Rheumatology, Department of Pediatrics, Hassenfeld Children's Hospital at NYU Langone Health, NYU Grossman School of Medicine, New York, New York.
⁵ Division of Pediatric Rheumatology, Department of Pediatrics, Hassenfeld Children's Hospital at NYU Langone Health, NYU Grossman School of Medicine, New York, New York; The Ronald O. Perelman Department of Dermatology at NYU Langone, New York, New York.
⁶ The Ronald O. Perelman Department of Dermatology at NYU Langone, New York, New York.

Katharina S Shaw et al. J Am Acad Dermatol. 2024 Dec.

. 2024 Dec;91(6):1217-1219.

doi: 10.1016/j.jaad.2024.07.1491. Epub 2024 Aug 12.

¹ Section of Dermatology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: katharina.shaw@pennmedicine.upenn.edu.
² Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Dermatology Program, Division of Immunology, Boston Children's Hospital, Boston, Massachusetts.
³ Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
⁴ Division of Pediatric Rheumatology, Department of Pediatrics, Hassenfeld Children's Hospital at NYU Langone Health, NYU Grossman School of Medicine, New York, New York.
⁵ Division of Pediatric Rheumatology, Department of Pediatrics, Hassenfeld Children's Hospital at NYU Langone Health, NYU Grossman School of Medicine, New York, New York; The Ronald O. Perelman Department of Dermatology at NYU Langone, New York, New York.
⁶ The Ronald O. Perelman Department of Dermatology at NYU Langone, New York, New York.

No abstract available

Keywords: anifrolumab; dermatomyositis; refractory; type I interferon.

Conflict of interest statement

Conflicts of interest None disclosed.